RNTX

Conviction 0HealthcareScan · Fri, Jun 26, 2026

Piercing line

RNTX$0.9707+3.77%

ResistanceSupportVol 14

Vol MA14 679.97K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Rein Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.reintx.com ↗

Price0.9707

Change+3.77%

Gap-1.96%

Rel volume0.92×

Avg volume642.2K

Avg $ vol613.87K

SMA 200.9661

SMA 501.16

SMA 2001.27

Price vs 50-16.30%

Price vs 200-23.62%

MA stackbearish

50/200 cross—

Supertrenddown · 1.16

RSI (14)47

MACD hist0.02

MACD crossbull · 9d

Stoch %K / %D61 / 59

ADX (14)13

+DI / −DI17 / 20

RSI divergence—

MACD divergenceBullish

ATR %+9.21%

ADR %8.47%

52w high1.88

52w low0.8649

From 52w high-48.37%

Above 52w low+12.23%

New 52w highNo

SqueezeOn · 19d

Bollinger width24.26%

%B0.52

Donchian pos34.85%

Donchian high1.17

Donchian low0.8641

AVWAP (52w high)1.44

vs AVWAP high-32.44%

AVWAP (52w low)0.9286

vs AVWAP low+4.54%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d0.92×

Avg vol (14d)679.97K

Avg vol (20d)642.2K

Avg $ vol (20d)613.87K

Market cap—

RS 3m (vs SPY)-39.84%

RS 6m (vs SPY)-41.35%

RS line new highNo

Trend template0/8

Technical rank16.7

1 week+6.01%

1 month-8.42%

3 months-23.57%

6 months-28.10%

1 year-36.97%

YTD-22.34%

P/E-1.61

P/B6.91

P/S—

P/FCF-4.10

EPS-1.96

Div yield—

ROE-430.26%

ROA-189.71%

Debt/Eq—

Current0.40

EV/EBITDA-1.49

Gross margin—

Net margin—

Rev growth—

EPS growth20.69%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value75.66M

Revenue0

Net income-5.84M

Gross profit—

Free cash flow-19.52M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out85.54M

Employees10

ListedThu, Jun 29, 2017

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank16.7 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmPiercing line

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RNTX

All disclosures →

No recent disclosed trades by Congress in RNTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RNTX

No recent insider (Form 4) filings in RNTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in RNTX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.